Rheumatoid Arthritis Clinical Trials in Houston

Showing 41-60 of 1,660 trials

PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)

NCT05037292

The PAUSE Trial is a pragmatic, randomized clinical trial for Veterans scheduled for elective surgery at 3 large VA facilities (Palo Alto, Houston, and Nashville). The PAUSE Trial focuses on cooperation between providers of various disciplines in order to provide better care. Veterans identified as frail upon standardized will be referred to a multidisciplinary "PAUSE Board" comprised of members from surgery, anesthesia, geriatrics, palliative care, case management, rehabilitation, and nutrition. Diverse specialists will come together in a team environment to discuss care options, scientific evidence, and patient goals and expectations, creating individual patient recommendations. The investigators hypothesize that the PAUSE Board model will improve quality and outcomes by promoting guidelines and evidence-based care recommendations as well as constructive team-based discussions to align care with patient goals and expectations.

Frailty

VA Office of Research and Development35,015 participantsStarted Oct 2021

Palo Alto, California, United States • Nashville, Tennessee, United States • Houston, Texas, United States

ACTIVE_NOT_RECRUITINGNA< 1 mile

Evolut™ EXPAND TAVR II Pivotal Trial

NCT05149755

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Moderate Aortic Valve Stenosis

Medtronic Cardiovascular650 participantsStarted Apr 2022

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +91 more locations

PAtient-centered mUltidiSciplinary Care for vEterans Undergoing Surgery (PAUSE)

Evolut™ EXPAND TAVR II Pivotal Trial

Rheumatoid Arthritis Trials in Other Cities

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Radiofrequency Ablation For Recurrent Parathyroid Carcinoma

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Terumo Aortic Global Endovascular Registry

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

Other Conditions in Houston